Structural and Functional Insights into the HIV-1 Maturation Inhibitor Binding Pocket

• Kayoko Waki,

  Affiliation Virus-Cell Interaction Section, HIV Drug Resistance Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Stewart R. Durell,

  Affiliation Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Ferri Soheilian,

  Affiliation Electron Microscope Laboratory, Advanced Technology Program, SAIC-Frederick, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Kunio Nagashima,

  Affiliation Electron Microscope Laboratory, Advanced Technology Program, SAIC-Frederick, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Scott L. Butler,

  Current address: Infection Innovative Medicine, AstraZeneca Pharmaceuticals, Waltham, Massachusetts, United States of America

  Affiliation Antiviral Biology, Pfizer Global Research & Development, Sandwich Laboratories, Sandwich, Kent, United Kingdom

  ⨯
• Eric O. Freed

  * E-mail: efreed@nih.gov

  Affiliation Virus-Cell Interaction Section, HIV Drug Resistance Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯